Page last updated: 2024-09-04

cositecan and Benign Neoplasms, Brain

cositecan has been researched along with Benign Neoplasms, Brain in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Batchelor, T; Carson, KA; Grossman, SA; Hausheer, F; Lesser, G; Nabors, LB; Peereboom, D; Phuphanich, S; Supko, JG	1
Bigner, DD; Friedman, HS; Hausheer, F; Keir, ST; Lawless, AA	1

Trials

1 trial(s) available for cositecan and Benign Neoplasms, Brain

Article	Year
Phase I and pharmacokinetic study of karenitecin in patients with recurrent malignant gliomas. Neuro-oncology, 2008, Volume: 10, Issue:4 Topics: Adult; Aged; Anticonvulsants; Antineoplastic Agents; Brain Neoplasms; Camptothecin; Drug Interactions; Female; Glioma; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local	2008

Other Studies

1 other study(ies) available for cositecan and Benign Neoplasms, Brain

Article	Year
Therapeutic activity of 7-[(2-trimethylsilyl)ethyl)]-20 (S)-camptothecin against central nervous system tumor-derived xenografts in athymic mice. Cancer chemotherapy and pharmacology, 2001, Volume: 48, Issue:1 Topics: Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Camptothecin; Female; Humans; Irinotecan; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Transplantation, Heterologous	2001

Article

Year

Therapeutic activity of 7-[(2-trimethylsilyl)ethyl)]-20 (S)-camptothecin against central nervous system tumor-derived xenografts in athymic mice.

Cancer chemotherapy and pharmacology, 2001, Volume: 48, Issue:1

Topics: Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Camptothecin; Female; Humans; Irinotecan; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Transplantation, Heterologous

2001